Bitcoin (BTC) whales and spot exchange-traded funds (ETFs) are absorbing supply, yet on-chain data shows the wider recovery still lacks depth. Strong accumulation now sits against weak network activity and thinning liquidity, suggesting the market has not yet moved from a fragile bounce to a durable trend. The
Elon Musk’s Terafab chip project is suddenly real, and it has dragged one US stock back into focus. Months ago Musk tied the giant plant to Intel (INTC) and its most advanced technology, and now that Terafab is funded, that endorsement matters again. Intel stock still slipped about 4% on August 10 to near $97,
TRON (TRX) is winning as a stablecoin settlement rail even as its Decentralized Finance (DeFi) economy contracts, a divide that is quite evident through the second quarter of 2026. Record payment flows keep moving across the network, yet that liquidity is largely skipping its trading and lending venues. The chain now
Zoomex has expanded its Stock Perpetuals lineup with twelve new USDT margined contracts, giving traders around-the-clock exposure to some of the most closely watched names in U.S. equities. UnitedHealth Group (UNH), General Electric (GE), JPMorgan Chase (JPM), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN),
Bitget, the world’s largest Universal Exchange (UEX), has released its latest Protection Fund report, showing an average valuation of $351 million in July 2026 as Bitcoin recovered through July, lifting the fund’s U.S. dollar valuation. The Protection Fund reached a monthly high of $365.9 million on July 21 and